SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study.

Cao, Yubin; Feng, Jiaming; Duan, Shihao; Yang, Yi; Zhang, Yan

Cao, Yubin; Feng, Jiaming; Duan, Shihao; Yang, Yi; Zhang, Yan.

Afiliação

Cao Y; Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, P.R. China.
Feng J; West China School of Medicine, Sichuan University, Chengdu, P.R. China.
Duan S; Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, P.R. China.
Yang Y; Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, P.R. China.
Zhang Y; Department of Gastroenterology, West China Hospital, Sichuan University, No. 37 Guoxue Street, Chengdu 610041, Sichuan, P.R. China.

Therap Adv Gastroenterol ; 15: 17562848221101722, 2022.

Article em En | MEDLINE | ID: mdl-35706827

Palavras-chave

COVID-19; IBD; SARS-CoV-2-inactivated vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Therap Adv Gastroenterol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google